ProCE Banner Activity

Novel Therapeutics for HR+/HER2- Metastatic Breast Cancer

Slideset Download
Download this slideset to explore future directions in the treatment of HR+/HER2- metastatic breast cancer, including a review of novel agents in the setting of resistance to standard-of-care therapies.

Released: December 11, 2019

Expiration: December 09, 2020

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Immunomedics

Lilly